Ledger.Open graph →
SEC Form D · Amendment · filed July 3, 2014

Tocagen Inc

Offering
$15.8M
Sold
$8.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Renato A. Mazzolini · Nassau, C5Exec · DirectorMaxwell E. A · Maitland, FLExecRick H. Walsh · Orlando, FLExec · DirectorBarry Lieberman · Santa Barbara, CAExec · DirectorEli Aizenstat · Santa Barbara, CAExec · DirectorJenny Abramson · White Plains, NYExec · DirectorChristopher A. Mccain · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗